Next-Generation Prebiotics for Food Allergy Management: Targeting Gut Microbiota for Immune Tolerance

Vol. 31, Issue 3 (September 2026)

Akhila P. P., MSc
Research Scholar, Biochemistry
Department of Life Science
University of Calicut
Kerala, India
 

B.S. Harikumaran Thampi, PhD
Professor, Biochemistry
Department of Life Science
University of Calicut
Kerala, India

 

Abstract

Diet, genetics, and environment play a critical role in food allergies development which are rapidly increasing in developed countries. Modulating gut microbiota as a novel dietary approach capable of preventing food allergies is increasingly becoming of interest. If you get enough prebiotics (non-digestible fibers that stimulate the growth of beneficial gut bacteria) through diet this can help to boost immune tolerance and reduce allergic responses according to research.  Many alternative therapies, human milk oligosaccharides (HMOs), galacto-oligosaccharides (GOS), and a novel source like Sanwa rice have been used in the food allergic state. They contribute to immune modulation via their capacity to induce the production of short-chain fatty acids (SCFAs) and improving gut-intestinal barrier integrity. Humans' trials as well as several animal models demonstrate a beneficial effect of prebiotics on the severity of food allergy and these results suggest that they could be an attractive therapeutic target for the future.

Keywords: prebiotics, gut microbiota, food allergy treatment, novel prebiotics, prebiotics mechanisms

Introduction

Microbiomes are significant components of the human body containing a vast array of microorganisms. The human gut microbiota is a large community specializing in microorganisms that have immense implications on health and disease. It affects metabolism, fights pathogens, and regulates the immune system. There is mounting evidence supporting gut microbial dysbiosis as an important contributor, particularly amongst children, to the development of food allergy and intolerance syndromes. About 5–10% of people in developed countries have food allergies, which are intimately associated with microbiota disruption and leaky gut leading to immune dysregulation. However, diet, medication, and environmental context to which children are exposed to can also influence gut microbiome composition, raising the necessity for dietary interventions such as prebiotics that may reset the dysbiosis and promote an immune tolerance switch.^{1, 2}

Diet plays a major influence in altering the gut flora.  Consumption of some types of food modifies the composition of intestinal microbe communities by boosting the abundance of bacteria. The chance of developing some diseases can be lowered by including better dietary alternatives in regular meals.³

Prebiotics are non-digestible dietary ingredients that target the composition and activity of the gut microbiota in a functional way. Their capacity allows selectively provided growth and activities of beneficial bacteria in the gut ecosystem, mainly Bifidobacterium and Lactobacillus species, which has been associated with regulation of local mucosal immune function and prevention of allergic diseases.^{4, 5}

This review examines recent developments in the use of prebiotics for food allergy treatment, focusing on their mechanisms of action, clinical evidence, and insights from animal models.

Gut Microbiota and Immune Tolerance

The gut microbiota is important for the development of the immune system, especially in relation to the establishment of oral tolerance—a phenomenon where the immune system tolerates food antigens without resulting in an allergic reaction. There are a few big mechanisms that contribute to immune tolerance mediated by the gut microbiota, including:

1. Regulatory T Cells (Tregs)
   Some gut bacteria, such as Bifidobacterium and Clostridia, drive the expansion of Tregs that are involved in suppressing excessive immune responses and promoting tolerance to food antigens.
2. Short Chain Fatty Acids (SCFAs)
   Fermentation of dietary fibers by beneficial bacteria results in the production of SCFAs like butyrate, acetate, and propionate. SCFAs improve the integrity of the intestinal barrier, tone down immune cells, and are anti-inflammatory.
3. Immune System Development
   Microbes exposure early in life shape immunity. Perturbations in the early microbiome (e.g. antibiotic use or c-section birth) has been linked to subsequent food allergy protection. Here, we consider the location effects of these two potential factors as well as their combined effect on food allergies.^{6, 7}

Dysbiosis and the Emergence of Food Allergies

Multiple studies have shown differences between the gut microbiota compositions of healthy individuals and those with food allergies. Dysbiosis involves the following:

• Reduced microbial diversity
  Individuals engineered to develop allergic responses tended to have lower overall gut microbial diversity in association with reduced functional maturation of the immune system.
• Imbalance between bacteria
  Food allergy sufferers have a reduced abundance of beneficial bacteria, particularly Bifidobacterium and Lactobacillus, and an increase in harmful bacteria like Escherichia coli as well as Clostridium difficile. These imbalances create a so-called leaky gut, or increased intestinal permeability, through which allergens pass causing allergy related symptoms.^{8, 9}

Prebiotics

Prebiotics are non-digestible dietary fibers that stimulate the growth of beneficial bacteria. Prebiotics work as food for good gut bacteria, boosting their growth and activity in the colon and improving overall gut health. Compounds such as insulin, fruit-oligosaccharides, manna-oligosaccharides, and resistant starch are prebiotic dietary fibers that are not digested in the upper gastrointestinal tract but selectively stimulate good gut microbes to help digestion. They provide a variety of health benefits by modifying the microbiome, including gut health maintenance, increased calcium absorption, cancer prevention, and immune system enhancement. Prebiotics also enhance gut mucosal integrity and lipid metabolism, potentially replacing antibiotics in animals. In addition, they have the ability to reduce diet-related disorders and improve food product quality. Undigested dietary items that enter the colon are selectively fermented by beneficial bacteria such as bifidobacteria and lactobacilli, promoting a healthy intestinal flora. The increased demand for prebiotics has resulted in their inclusion into functional foods.^{4, 5, 10}

Mechanism of Action

Prebiotics will help to promote immune tolerance and reducing allergic responses, by acting on the gut microbiota via different mechanisms, including:

1. Stimulation of beneficial aspects
   Prebiotics specifically stimulate the growth of some specific bacteria flora, such as Lactobacillus and Bifidobacterium that modulate immunity and maintain gut barrier integrity.
2. Production of SCFAs
   Prebiotics (e.g. inulin, fructo-oligosaccharides) are fermented by gut bacteria to generate SCFAs that promote anti-inflammatory effects, reduces inflammation, and enhances gut mucosal integrity and immune tolerance.
3. Modulation of immune responses
   Prebiotics, particularly more insoluble fibers, stimulate the production of cytokines and immunoglobulins to modulate immune responses, thus making individuals better able to tolerate any food antigens.
4. Competing with pathogens
   Prebiotics help in inhibiting the growth of pathogenic bacteria by creating an environment favorable for beneficial bacteria to grow, and beneficial species effectively outcompete pathogenic species for resources to the colonization sites. Additionally, by altering the gut flora, they may improve the effectiveness of cancer therapies like chemotherapy.^{4, 10–13}

The role of traditional prebiotics in managing food allergies is gaining attention due to their potential to modulate gut microbiota and enhance immune tolerance. Research indicates that prebiotics, such as galactic-oligosaccharides (GOS) and insulin, can significantly influence the gut microbiome, promoting beneficial bacterial strains that may reduce the risk of food allergies in offspring when administered during pregnancy. Prebiotics are helpful, but their effects can differ depending on the makeup of each person's gut microbiota, indicating the necessity for individualized methods when using them.^14–16

Novel Prebiotics for Allergy Management

New prebiotics with potential effect on management of food allergies have been described in a recent study.

Human Milk Oligosaccharides (HMOs)

HMOs, which are naturally contained in breast milk, encourage the growth of healthy gut bacteria and help children build their immune systems. Clinical research indicate that HMOs may lessen allergy responses by increasing gut bacteria diversity and immunological function.¹⁷

Beta-glucans

Derived from oats, mushrooms, and yeast, beta-glucans contain prebiotic properties that promote SCFA generation and improve immunological responses. Their effect in relieving food allergy symptoms is being investigated.¹⁸

Xylo-oligosaccharides (XOS)

Known for their significant bifidogenic qualities, XOS increase gut microbial diversity and may lower the risk of food allergies by improving gut health.¹⁹

Polydextrose

A second case in functionalized glucose polymer not only shows prebiotic potential (an effect on microbiota richness and SCFA production) but also some effectiveness in reducing allergic reactions.²⁰

Oligosaccharides derived from Pectin

his type of oligosaccharide is obtained from the cell walls of fruits and helps in sustaining beneficial bacteria like Faecalibacterium prausnitzii, which is known for its anti-inflammatory characteristics.²¹

Resistant Dextrin

A type of prebiotic that has been shown to increase subjects gut microbiota diversity as well as decreased pro-inflammatory markers in clinical studies, making it an interesting compound for allergy prevention.²²

Algal prebiotics (Fucoidans and Laminarins)

Seaweed derived polysaccharides are able to selectively stimulate certain beneficial bacteria strains such as bifidobacteria and can also modulate immune response, making them a potential therapeutic approach for food allergy.²³

Clinical Evidence for Prebiotics in Food Allergy Treatment

Several clinical trials have been done to determine the effectiveness of new prebiotics in treating food allergies. Below are some significant findings:

1. Human Milk Oligosaccharides (HMO's) in Cow's Milk Allergy (CMA)
   Infants with cow's milk allergy (CMA) who received HMO-supplemented formula had less allergic symptoms and lower levels of cow's milk-specific IGE. HMO promoted the growth of Bifidobacterium species, which improved gut microbial diversity and immunological tolerance.²⁴
2. Galacto-Oligosaccharides (GOS) in allergy prevention
   Early-life supplementation with Galacto-Oligosaccharides (GOS) can prevent food allergies, according to a study of newborns. GOS increased gut microbial composition by raising Bifidobacterium numbers, which aid immune modulation and reduces inflammation.²⁵
3. Fructo-Oligosaccharides (FOS) in multiple food allergies
   FOS, which is often present in plants such as chicory and onions, has been studied for its potential involvement in controlling numerous food allergies. In one study, children with numerous food allergies who took FOS supplements had improved gut barrier function, fewer allergy symptoms, and greater tolerance to allergens.²⁶
4. Synbiotic Strategies
   The fusion of prebiotics and probiotics (synbiotics) has unveiled promising prospects in animal research, revealing enhanced immune acceptance and diminished allergy manifestations when employing GOS alongside select bacterial varieties.²⁷

Preclinical Research Provides Insights into Animal Models

Animal models have offered useful information about the potential of prebiotics in food allergy treatment. In a wheat gluten allergy mouse model, prebiotics produced from Sanwa rice's non-digestible fractions (NDF) were found to increase the growth of Faecalibacterium prausnitzii, a bacterium associated with anti-inflammatory properties.²⁸ Supplementing with Kylo-Oligosaccharides (LOS) in an albumin-sensitized Murine model reduced allergic symptoms, including lower IGE levels. It also increased the abundance of beneficial bacteria, particularly Akkermansia muciniphila, which has been linked to improved gut barrier function and immune tolerance.²⁹

Arabinogalactans, or plant-derived polysaccharides, were evaluated in a Murine model for peanut allergy. Mice treated with arabinogalactans produced more SCFA and had an increase in good gut bacteria including Lactobacillus and Bifidobacterium.³⁰

These animal models provide important insights into how prebiotics can be utilized to alter the gut and lessen allergy symptoms, with potential therapeutic applications in human food allergies.

Conclusion

The use of prebiotics in food allergy treatment is a unique and promising strategy to altering gut microbiota and improving immunity. Clinical trials and preclinical research have demonstrated that new prebiotics, including HMOs, GOS, and Sanwa rice-derived prebiotics can successfully reduce allergic responses and enhance gut health. New research indicates that prebiotics can be engineered to produce immune tolerance to particular allergens, such as peanuts. What's more promising in this sense is the research conducted this year, wherein gut microflora modulation could have a beneficial effect on allaying allergic reactions to specific food triggers, offering a novel approach to targeted prebiotic therapies.

References

1. E. Rinninella et al., “What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases,” Microorganisms, vol. 7, no. 1, Jan. 2019, doi: 10.3390/microorganisms7010014.
2. T. Requena and M. Velasco, “Microbioma humano en la salud y la enfermedad. Title: Human microbiome in health and disease Concepción y diseño del manuscrito: Teresa Requena. Redacción, revisión, aprobación del manuscrito remitido: Teresa Requena y María.”
3. M. A. Conlon and A. R. Bird, “The impact of diet and lifestyle on gut microbiota and human health,” Dec. 24, 2015, MDPI AG. doi: 10.3390/nu7010017.
4. D. Davani-Davari et al., “Prebiotics: Definition, types, sources, mechanisms, and clinical applications,” Mar. 01, 2019, MDPI Multidisciplinary Digital Publishing Institute. doi: 10.3390/foods8030092.
5. G. R. Gibson et al., “Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics,” Aug. 01, 2017, Nature Publishing Group. doi: 10.1038/nrgastro.2017.75.
6. H. J. Wu and E. Wu, “The role of gut microbiota in immune homeostasis and autoimmunity,” 2012, Landes Bioscience. doi: 10.4161/gmic.19320.
7. Y. B. Kang, Y. Cai, and H. Zhang, “Gut microbiota and allergy/asthma: From pathogenesis to new therapeutic strategies,” May 01, 2017, Elsevier Doyma. doi: 10.1016/j.aller.2016.08.004.
8. J. Liang, B. Zheng, Y. Zhang, and H. Zeng, “Food allergy and gut microbiota,” Oct. 01, 2023, Elsevier Ltd. doi: 10.1016/j.tifs.2023.104141.
9. Y. Cheng et al., “The Roles and Mechanisms of Gut Microbiota in Food Allergy,” Advanced Gut & Microbiome Research, vol. 2023, pp. 1–16, Apr. 2023, doi: 10.1155/2023/9575410.
10. J. F. Ribeiro and C. Pedrosa, “Probiotics, prebiotics and food allergy: a review,” May 01, 2024, EDRA S.p.A. doi: 10.23822/EurAnnACI.1764-1489.319.
11. S. Sestito et al., “The Role of Prebiotics and Probiotics in Prevention of Allergic Diseases in Infants,” Dec. 22, 2020, Frontiers Media S.A. doi: 10.3389/fped.2020.583946.
12. S. Chan et al., “PREBIOTIC: a study protocol of a randomised controlled trial to assess prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset — a feasibility study,” Pilot Feasibility Study, vol. 9, no. 1, Dec. 2023, doi: 10.1186/s40814-023-01236-y.
13. “Impact of Prebiotics in Allergic Prevention - Danone Nutricia Academy”.
14. Shreya Singh and Neetu Singh, “Development of probiotics and prebiotics product as weaning food for infants,” World Journal of Advanced Research and Reviews, vol. 17, no. 1, pp. 073–076, Jan. 2023, doi: 10.30574/wjarr.2023.17.1.1376.
15. M. Zhao et al., “Effects of prebiotics on the fermentation of traditional suancai of Northeast China,” Food Science and Human Wellness, vol. 13, no. 3, pp. 1358–1367, May 2024, doi: 10.26599/FSHW.2022.9250114.
16. S. Sharif, S. J. Oddie, P. T. Heath, and W. McGuire, “Prebiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants,” Cochrane Database of Systematic Reviews, vol. 2021, no. 8, Aug. 2021, doi: 10.1002/14651858.CD015133.
17. A. Adegbola, C.-A. Behrendt, B.-C. Zyriax, E. Windler, and T. Kreutzburg, “The impact of nutrition on the development and progression of peripheral artery disease: A systematic review,” Clinical Nutrition, vol. 41, no. 1, pp. 49–70, Jan. 2022, doi: 10.1016/j.clnu.2021.11.005.
18. B. C. A. M. et al. (2017) van Esch, “Cross-talk between peanut allergy and gut microbiota in mice is associated with microbial and immunological shifts,” mucosa limmunology.
19. T., et al. Yamagishi, “Prebiotic potential of Sanwa rice: Impact on gut microbiota and immune modulation.,” Food Funct, vol. 12, no. 7, pp. 3555-3566., 2021.
20. L., et al. Arola, “‘Gut Microbiota Modulation by Polydextrose and its Impact on Metabolic Health.’,” Nutrients, 2021.
21. G., et al Oliveira, “‘Impact of Pectin-Derived Oligosaccharides on Gut Microbiota and Immune Modulation.,’” BMC Microbiome. BioMed Central, 2022.
22. X., et al Liu, “‘Effects of Resistant Dextrin on Gut Microbiota and Immune Function.’,” Molecules, 2023.
23. J., et al. Kim, “‘Algal Polysaccharides in Gut Microbiota Modulation and Immunomodulation.’,” BMC Gastroenterology. BioMed Central., 2022.
24. P. A. Eigenmann et al., “Addressing risk management difficulties in children with food allergies,” Pediatric Allergy and Immunology, vol. 32, no. 4, pp. 658–666, May 2021, doi: 10.1111/pai.13455.
25. C., & W. U. Grüber, “Early Supplementation with Galacto-Oligosaccharides in Infants: Impact on Allergy Development.,” Clinical and Experimental Allergy, pp. 40(3), 305–313, 2021.
26. S., & B. G. alminen, “Fructo-Oligosaccharides and Food Allergy Modulation in Children: A Clinical Perspective.,” Pediatric Allergy and Immunology, pp. 32(1), 12-20., 20213.
27. K. Trone, S. Rahman, C. H. Green, C. Venegas, R. Martindale, and A. Stroud, “Synbiotics and Surgery: Can Prebiotics and Probiotics Affect Inflammatory Surgical Outcomes?” Jun. 01, 2023, Springer. doi: 10.1007/s13668-023-00464-1.
28. H., & T. K. Yamamoto, “Prebiotics from Sanwa Rice Non-Digestible Fractions Modulate Gut Microbiota and Alleviate Wheat Gluten Allergy in a Mouse Model,” Journal of Nutritional Biochemistry, 2020.
29. B. Raud, P. J. McGuire, R. G. Jones, T. Sparwasser, and L. Berod, “Fatty acid metabolism in CD 8 ⁺ T cell memory: Challenging current concepts,” Immunol Rev, vol. 283, no. 1, pp. 213–231, May 2018, doi: 10.1111/imr.12655.
30. K. S. Avdeeva, S. Reitsma, and W. J. Fokkens, “Direct and indirect costs of allergic and non‐allergic rhinitis in the Netherlands,” Allergy, vol. 75, no. 11, pp. 2993–2996, Nov. 2020, doi: 10.1111/all.14457.